NewEdge Advisors’s iRadimed IRMD Stock Holding History

NewEdge Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.65M	Sell	17,191 -65	-0.4%	-$6.5K	0.01%	1203
2025 Q4	$1.68M	Buy	+17,256	New	+$1.48M	0.01%	1163
2025 Q1	–	Sell	-3	Closed	-$165	–	4041
2024 Q4	$165	Hold	3	–	–	﹤0.01%	3755
2024 Q3	$151	Hold	3	–	–	﹤0.01%	3697
2024 Q2	$132	Buy	+3	New	+$128	﹤0.01%	3674
2023 Q2	–	Sell	-132	Closed	-$5.2K	–	3561
2023 Q1	$5.2K	Hold	132	–	–	﹤0.01%	2760
2022 Q4	$4	Buy	+132	New	+$3.78K	﹤0.01%	3846

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewEdge Advisors's IRMD Position: Q1 2026 in Review

NewEdge Advisors reduced its iRadimed (IRMD) stake by 0.38% in Q1 2026, selling an estimated $6.5K and leaving 17,191 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #1203.

NewEdge Advisors first reported a position in IRMD in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.68M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

NewEdge Advisors held 17,191 shares of iRadimed worth $1.65M as of Q1 2026.
NewEdge Advisors sold 65 iRadimed shares in Q1 2026, an estimated $6.5K.
iRadimed made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1203 holding.
NewEdge Advisors first reported a position in iRadimed in Q4 2022 and has held it in 7 quarters since.
NewEdge Advisors's iRadimed position peaked at $1.68M in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.